Tumour Lysis Syndrome

Oncology

Massive tumour cell breakdown releasing potassium, phosphate and nucleic acids, causing hyperuricaemia and acute kidney injury.

Investigations

  • • Potassium, phosphate, calcium, urate, creatinine 6–12 hourly
  • • LDH, ECG for hyperkalaemia
  • • Urine output monitoring

Management

  • • IV fluids 2–3 L/m²/day to maintain high urine output
  • • Allopurinol for low/intermediate risk; rasburicase for high risk
  • • Treat hyperkalaemia aggressively
  • • Avoid calcium unless symptomatic hypocalcaemia
  • • Renal replacement if refractory

Clinical pearls

  • • Highest risk in Burkitt lymphoma, ALL and bulky high-grade lymphoma
  • • Do not alkalinise urine routinely — promotes calcium phosphate deposition

Related in WardRound

Educational — verify locally.

WardRound

WardRound

Clinical Decisions in Seconds